blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP1687019

EP1687019 - PROPYLENE GLYCOL-CONTAINING PEPTIDE FORMULATIONS WHICH ARE OPTIMAL FOR PRODUCTION AND FOR USE IN INJECTION DEVICES [Right-click to bookmark this link]
StatusOpposition rejected
Status updated on  20.01.2023
Database last updated on 28.03.2025
FormerThe patent has been granted
Status updated on  20.10.2017
FormerGrant of patent is intended
Status updated on  11.09.2017
FormerExamination is in progress
Status updated on  05.04.2017
Most recent event   Tooltip20.01.2023Opposition rejectedpublished on 22.02.2023  [2023/08]
Applicant(s)For all designated states
NOVO NORDISK A/S
Novo Allé
2880 Bagsværd / DK
[2017/47]
Former [2006/32]For all designated states
NOVO NORDISK A/S
Novo Allé
2880 Bagsvaerd / DK
Inventor(s)01 / PEDERSEN, Tina Bjeldskov
Østerhøjvej 50
DK-2750 Ballerup / DK
02 / BONDE, Claude
Borgevej 41 B
DK-2800 Lyngby / DK
03 / ENGELUND, Dorthe Kot
Dorthe Kot Engelund
Gassehaven 39
DK-2840 Holte / DK
 [2017/41]
Former [2006/32]01 / PEDERSEN, Tina Bjeldskov
Osterhojvej 50
DK-2750 Ballerup / DK
02 / BONDE, Claude
Borgevej 41 B
DK-2800 Lyngby / DK
03 / ENGELUND, Dorthe Kot
Dorthe Kot Engelund, Gassehaven 39
DK-2840 Holte / DK
Representative(s)Potter Clarkson
Chapel Quarter
Mount Street
Nottingham NG1 6HQ / GB
[N/P]
Former [2017/47]Nielsen, Lars Balzer, et al
Novo Nordisk A/S
Corporate Patents
Novo Allée
2880 Bagsvaerd / DK
Former [2006/32]Nielsen, Lars Balzer, et al
Novo Nordisk A/S Corporate Patents Novo Allée
2880 Bagsvaerd / DK
Application number, filing date04797453.018.11.2004
[2006/32]
WO2004DK00792
Priority number, dateDK2003000171920.11.2003         Original published format: DK 200301719
[2006/32]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO2005049061
Date:02.06.2005
Language:EN
[2005/22]
Type: A2 Application without search report 
No.:EP1687019
Date:09.08.2006
Language:EN
The application published by WIPO in one of the EPO official languages on 02.06.2005 takes the place of the publication of the European patent application.
[2006/32]
Type: B1 Patent specification 
No.:EP1687019
Date:22.11.2017
Language:EN
[2017/47]
Search report(s)International search report - published on:EP20.10.2005
ClassificationIPC:A61K9/00, A61K38/26, A61K38/28, A61K47/10, A61K47/18, A61K47/20, A61K47/26
[2017/40]
CPC:
A61K47/10 (EP,KR,US); A61K38/28 (EP,KR,US); A61K38/26 (EP,US);
A61K47/183 (EP,US); A61K47/20 (EP,KR,US); A61K47/26 (EP,US);
A61K9/0019 (EP,US); A61P3/04 (EP); A61P3/10 (EP);
A61P5/48 (EP); A61P5/50 (EP) (-)
Former IPC [2006/32]A61K38/26, A61K38/27, A61K38/28
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LU,   MC,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2017/47]
Former [2006/32]AT,  BE,  BG,  CH,  CY,  CZ,  DE,  DK,  EE,  ES,  FI,  FR,  GB,  GR,  HU,  IE,  IS,  IT,  LI,  LU,  MC,  NL,  PL,  PT,  RO,  SE,  SI,  SK,  TR 
TitleGerman:FÜR DIE HERSTELLUNG UND VERWENDUNG IN INJEKTIONSVORRICHTUNGEN OPTIMALE PROPYLENGLYKOL ENHALTENDE PEPTIDFORMULIERUNGEN[2006/32]
English:PROPYLENE GLYCOL-CONTAINING PEPTIDE FORMULATIONS WHICH ARE OPTIMAL FOR PRODUCTION AND FOR USE IN INJECTION DEVICES[2006/32]
French:FORMULATIONS PEPTIDIQUES A BASE DE PROPYLENE GLYCOL OPTIMALES POUR LA PRODUCTION ET L'UTILISATION DANS DES DISPOSITIFS D'INJECTION[2006/32]
Entry into regional phase20.06.2006National basic fee paid 
20.06.2006Designation fee(s) paid 
20.06.2006Examination fee paid 
Examination procedure20.06.2006Examination requested  [2006/32]
12.03.2009Despatch of a communication from the examining division (Time limit: M06)
15.09.2009Reply to a communication from the examining division
11.04.2013Despatch of a communication from the examining division (Time limit: M06)
21.10.2013Reply to a communication from the examining division
27.03.2017Despatch of a communication from the examining division (Time limit: M04)
20.07.2017Reply to a communication from the examining division
12.09.2017Communication of intention to grant the patent
11.10.2017Fee for grant paid
11.10.2017Fee for publishing/printing paid
11.10.2017Receipt of the translation of the claim(s)
Divisional application(s)EP11157594.0  / EP2394656
EP17196501.5  / EP3300721
The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  12.03.2009
Opposition(s)Opponent(s)01  20.08.2018  28.08.2018  ADMISSIBLE
Sandoz AG
Lichtstrasse 35
4056 Basel / CH
Opponent's representative
Elkington and Fife LLP
Prospect House
8 Pembroke Road
Sevenoaks, Kent TN13 1XR / GB
 02  20.08.2018  28.08.2018  ADMISSIBLE
Fresenius Kabi Deutschland GmbH
Else-Kröner-Strasse 1
61352 Bad Homburg / DE
Opponent's representative
Fresenius Kabi Deutschland GmbH
Patent Department
Pharmaceuticals Division
Borkenberg 14
61440 Oberursel / DE
 03  21.08.2018  28.08.2018  ADMISSIBLE
Wittkopp, Alexander
Bogenallee 5
20144 Hamburg / DE
Opponent's representative
Hamm&Wittkopp Patentanwälte PartmbB
Jungfernstieg 38
20354 Hamburg / DE
 04  21.08.2018  28.08.2018  ADMISSIBLE
Teva Pharmaceutical Industries Ltd.
124 Dvora HaNevi'a St.
6944020 Tel Aviv / IL
Opponent's representative
Lederer & Keller Patentanwälte Partnerschaft mbB
Unsöldstraße 2
80538 München / DE
 05  21.08.2018  28.08.2018  ADMISSIBLE
Generics (U.K.) Limited
Building 4, Trident Place
Mosquito Way
Hatfield Herts AL 10 9UL / GB
Opponent's representative
Ter Meer Steinmeister & Partner
Patentanwälte mbB
Nymphenburger Straße 4
80335 München / DE
 06  22.08.2018  28.08.2018  ADMISSIBLE
Uexküll & Stolberg Partnerschaft von Patent- und Rechtsanwälten mbB
Beselerstrasse 4
22607 Hamburg / DE
Opponent's representative
Uexküll & Stolberg
Partnerschaft von
Patent- und Rechtsanwälten mbB
Beselerstraße 4
22607 Hamburg / DE
 [2021/48]
Former [2021/02]
Opponent(s)01  20.08.2018  28.08.2018  ADMISSIBLE
Sandoz AG
Lichtstrasse 35
4056 Basel / CH
Opponent's representative
Elkington and Fife LLP
Prospect House
8 Pembroke Road
Sevenoaks, Kent TN13 1XR / GB
 02  20.08.2018  28.08.2018  ADMISSIBLE
Fresenius Kabi Deutschland GmbH
Else-Kröner-Strasse 1
61352 Bad Homburg / DE
Opponent's representative
Fresenius Kabi Deutschland GmbH
Patent Department
Pharmaceuticals Division
Borkenberg 14
61440 Oberursel / DE
 03  21.08.2018  28.08.2018  ADMISSIBLE
Wittkopp, Alexander
Bogenallee 5
20144 Hamburg / DE
Opponent's representative
Hamm&Wittkopp Patentanwälte PartmbB
Jungfernstieg 38
20354 Hamburg / DE
 04  21.08.2018  28.08.2018  ADMISSIBLE
Teva Pharmaceutical Industries Ltd
5 Basel Street
49131 Petach-Tikva / IL
Opponent's representative
Lederer & Keller Patentanwälte Partnerschaft mbB
Unsöldstraße 2
80538 München / DE
 05  21.08.2018  28.08.2018  ADMISSIBLE
Generics (U.K.) Limited
Building 4, Trident Place
Mosquito Way
Hatfield Herts AL 10 9UL / GB
Opponent's representative
Ter Meer Steinmeister & Partner
Patentanwälte mbB
Nymphenburger Straße 4
80335 München / DE
 06  22.08.2018  28.08.2018  ADMISSIBLE
Uexküll & Stolberg Partnerschaft von Patent- und Rechtsanwälten mbB
Beselerstrasse 4
22607 Hamburg / DE
Opponent's representative
Uexküll & Stolberg
Partnerschaft von
Patent- und Rechtsanwälten mbB
Beselerstraße 4
22607 Hamburg / DE
Former [2019/49]
Opponent(s)01  20.08.2018  28.08.2018  ADMISSIBLE
Sandoz AG
Lichtstrasse 35
4056 Basel / CH
Opponent's representative
Elkington and Fife LLP
Prospect House
8 Pembroke Road
Sevenoaks, Kent TN13 1XR / GB
 02  20.08.2018  28.08.2018  ADMISSIBLE
Fresenius Kabi Deutschland GmbH
Else-Kröner-Strasse 1
61352 Bad Homburg / DE
Opponent's representative
Fresenius Kabi Deutschland GmbH
Patent Department
Pharmaceuticals Division
Borkenberg 14
61440 Oberursel / DE
 03  21.08.2018  28.08.2018  ADMISSIBLE
Wittkopp, Alexander
Bogenallee 5
20144 Hamburg / DE
Opponent's representative
Hamm&Wittkopp Patentanwälte PartmbB
Jungfernstieg 38
20354 Hamburg / DE
 04  21.08.2018  28.08.2018  ADMISSIBLE
Teva Pharmaceutical Industries Ltd
5 Basel Street
49131 Petach-Tikva / IL
Opponent's representative
Kalhammer, Georg
Lederer & Keller
Patentanwälte Partnerschaft mbB
Unsöldstrasse 2
80538 München / DE
 05  21.08.2018  28.08.2018  ADMISSIBLE
Generics (U.K.) Limited
Building 4, Trident Place
Mosquito Way
Hatfield Herts AL 10 9UL / GB
Opponent's representative
Ter Meer Steinmeister & Partner
Patentanwälte mbB
Nymphenburger Straße 4
80335 München / DE
 06  22.08.2018  28.08.2018  ADMISSIBLE
Uexküll & Stolberg Partnerschaft von Patent- und Rechtsanwälten mbB
Beselerstrasse 4
22607 Hamburg / DE
Opponent's representative
Uexküll & Stolberg
Partnerschaft von
Patent- und Rechtsanwälten mbB
Beselerstraße 4
22607 Hamburg / DE
Former [2018/39]
Opponent(s)01  20.08.2018   
Sandoz AG
Lichtstrasse 35
4056 Basel / CH
Opponent's representative
Prüfer & Partner mbB Patentanwälte · Rechtsanwälte
Sohnckestraße 12
81479 München / DE
 02  20.08.2018    ADMISSIBLE
Fresenius Kabi Deutschland GmbH
Else-Kröner-Strasse 1
61352 Bad Homburg / DE
Opponent's representative
Fresenius Kabi Deutschland GmbH
Patent Department
Pharmaceuticals Division
Borkenberg 14
61440 Oberursel / DE
 03  21.08.2018    ADMISSIBLE
Wittkopp, Alexander
Bogenallee 5
20144 Hamburg / DE
Opponent's representative
Hamm&Wittkopp Patentanwälte PartmbB
Jungfernstieg 38
20354 Hamburg / DE
 04  21.08.2018    ADMISSIBLE
Teva Pharmaceutical Industries Ltd
5 Basel Street
49131 Petach-Tikva / IL
Opponent's representative
Kalhammer, Georg
Lederer & Keller
Patentanwälte Partnerschaft mbB
Unsöldstrasse 2
80538 München / DE
 05  21.08.2018    ADMISSIBLE
Generics (U.K.) Limited
Building 4, Trident Place
Mosquito Way
Hatfield Herts AL 10 9UL / GB
Opponent's representative
Ter Meer Steinmeister & Partner
Patentanwälte mbB
Nymphenburger Straße 4
80335 München / DE
 06  22.08.2018    ADMISSIBLE
Uexküll & Stolberg Partnerschaft von Patent- und Rechtsanwälten mbB
Beselerstrasse 4
22607 Hamburg / DE
Opponent's representative
Uexküll & Stolberg
Partnerschaft von
Patent- und Rechtsanwälten mbB
Beselerstraße 4
22607 Hamburg / DE
06.09.2018Invitation to proprietor to file observations on the notice of opposition
15.01.2019Reply of patent proprietor to notice(s) of opposition
09.01.2020Date of oral proceedings
11.02.2020Despatch of minutes of oral proceedings
11.02.2020Date of despatch of rejection of opposition
11.11.2022Legal effect of rejection of opposition [2023/08]
Appeal following opposition18.03.2020Appeal received No.  T0605/20
19.06.2020Statement of grounds filed
11.11.2022Result of appeal procedure: appeal of the opponent was rejected
12.12.2022Despatch of the decision of the Board of Appeal
07.04.2020Appeal received No.  T0605/20
10.06.2020Statement of grounds filed
11.11.2022Result of appeal procedure: appeal of the opponent was rejected
12.12.2022Despatch of the decision of the Board of Appeal
28.02.2020Appeal received No.  T0605/20
10.06.2020Statement of grounds filed
11.11.2022Result of appeal procedure: appeal of the opponent was rejected
12.12.2022Despatch of the decision of the Board of Appeal
14.04.2020Appeal received No.  T0605/20
27.05.2020Statement of grounds filed
11.11.2022Result of appeal procedure: appeal of the opponent was rejected
12.12.2022Despatch of the decision of the Board of Appeal
11.11.2022Date of oral proceedings
Fees paidRenewal fee
30.11.2006Renewal fee patent year 03
30.11.2007Renewal fee patent year 04
01.12.2008Renewal fee patent year 05
30.11.2009Renewal fee patent year 06
30.11.2010Renewal fee patent year 07
30.11.2011Renewal fee patent year 08
30.11.2012Renewal fee patent year 09
02.12.2013Renewal fee patent year 10
01.12.2014Renewal fee patent year 11
30.11.2015Renewal fee patent year 12
30.11.2016Renewal fee patent year 13
13.10.2017Renewal fee patent year 14
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[A]WO9219260  (MOKS TOMAS [SE]);
 [X]US5206219  (DESAI ASHOK J [US]);
 [X]WO9323010  (SANDOZ AG [AT], et al);
 [A]WO9505848  (NOVO NORDISK AS [DK], et al);
 [X]WO9513825  (SEARLE & CO [US], et al);
 [A]WO9522560  (SYNTEX INC [US]);
 [X]WO9916417  (FLEMINGTON PHARMACEUTICAL CORP [US], et al);
 [A]WO02067989  (GRANDIS BIOTECH GMBH [DE], et al);
 [X]US2002151467  (LEUNG FRANK K [US]);
 [X]WO03013589  (UNIV HUAZHONG SCIENCE TECH [CN], et al);
 [XP]EP1424077  (UNIV HUAZHONG SCIENCE TECH [CN], et al);
 [E]WO2005046716  (NOVO NORDISK AS [DK], et al);
OppositionWO03002136
 US5216011
 US5981489
 WO9522560
 WO03033671
 WO2005046716
 WO9805351
 WO9830231
 WO0121198
 WO02067989
 US2005009742
 US6066619
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.